SCHEMBL158223

SCHEMBL158223

CCCCCCCCCCP(C)(C)=O

nearest known ligand 0.61

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 10/20 0.61
LPAR3 Q9UBY5 3/20 0.59
LPAR2 Q9HBW0 1/20 0.59
FAAH O00519 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10933278 1.00 TRPM8 (0.61) TRPM8LPAR3LPAR2FAAH
SCHEMBL992086 1.00 TRPM8 (0.61) TRPM8LPAR3LPAR2FAAH
SCHEMBL8581890 1.00 TRPM8 (0.61) TRPM8LPAR3LPAR2FAAH
SCHEMBL54150 1.00 TRPM8 (0.61) TRPM8LPAR3LPAR2FAAH
SCHEMBL10935189 1.00 TRPM8 (0.61) TRPM8LPAR3LPAR2FAAH
SCHEMBL408220 1.00 TRPM8 (0.61) TRPM8LPAR3LPAR2FAAH
SCHEMBL314020 1.00 TRPM8 (0.61) TRPM8LPAR3LPAR2FAAH
SCHEMBL224564 1.00 TRPM8 (0.61) TRPM8LPAR3LPAR2FAAH
SCHEMBL1725369 1.00 TRPM8 (0.61) TRPM8LPAR3LPAR2FAAH
SCHEMBL10935954 1.00 TRPM8 (0.61) TRPM8LPAR3LPAR2FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1757 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12597611-B2 Cathode for an electrochemical cell including at least one cathode additive DURACELL U.S. OPERATIONS, INC. (US) 2026-04-07 US claimed
US-20250073673-A1 NANONETS FOR REMOVAL OF CONTAMINANTS FROM AQUEOUS SOLUTIONS, KITS THEREFOR AND METHODS OF THEIR USE CARBONET NANOTECHNOLOGIES INC. (CA) 2025-03-06 US claimed
EP-4414063-A1 NANONETS FOR REMOVAL OF CONTAMINANTS FROM AQUEOUS SOLUTIONS, KITS THEREFOR AND METHODS OF THEIR USE Carbonet Nanotechnologies Inc. (CA) 2024-08-14 EP claimed
EP-2841943-B1 METHOD FOR CHARACTERIZING AND/OR DETERMINING SAMPLES KEMIRA OYJ (FI) 2023-09-27 EP claimed
US-11654103-B2 Skin care formulation EMBRYOGENESIS PTY LTD 2023-05-23 US claimed
CN-114681391-A Pharmaceutical product comprising a ROR gamma modulator 江苏恒瑞医药股份有限公司 2022-07-01 CN claimed
US-20210330579-A1 SKIN CARE FORMULATION EMBRYOGENESIS PTY LTD (AU) 2021-10-28 US claimed
US-20210322299-A1 SKIN CARE FORMULATION EMBRYOGENESIS PTY LTD (AU) 2021-10-21 US claimed
US-11075382-B2 Cathode for an electrochemical cell including at least one cathode additive DURACELL U.S. OPERATIONS, INC. (US) 2021-07-27 US claimed
CN-106716692-B Cathode for electrochemical cell comprising at least one cathode additive 杜拉塞尔美国经营公司 2021-01-29 CN claimed
EP-2362809-A2 PROCESS FOR ACCELERATED CAPTURE OF CARBON DIOXIDE Akermin, Inc. (US) 2011-09-07 EP claimed
WO-2010037109-A2 PROCESS FOR ACCELERATED CAPTURE OF CARBON DIOXIDE AKERMIN, INC. (US) 2010-04-01 WO claimed
EP-1069131-B1 Methods for separating particulate substrates from solution while minimizing particle loss QIAGEN GMBH (DE) 2006-03-15 EP claimed
WO-2003062461-A1 FMDV LEADER PEPTIDASE ASSAY AMURA THERPEUTICS LIMITED (GB) 2003-07-31 WO claimed
EP-0833939-B1 QUENCHING REAGENTS AND ASSAYS FOR ENZYME-MEDIATED LUMINESCENCE PROMEGA CORP (US) 2002-04-03 EP claimed
EP-0833939-A1 QUENCHING REAGENTS AND ASSAYS FOR ENZYME-MEDIATED LUMINESCENCE PROMEGA CORPORATION (US) 1998-04-08 EP claimed
US-5625053-A Method of isolating purified plasmid DNA using a nonionic detergent, solution BOARD OF REGENTS FOR NORTHERN ILLINOIS UNIV. (US) 1997-04-29 US claimed
WO-1996040988-A1 QUENCHING REAGENTS AND ASSAYS FOR ENZYME-MEDIATED LUMINESCENCE PROMEGA CORPORATION (US) 1996-12-19 WO claimed
US-4130667-A A SUCROSE ESTER AND A PHOSPHINE OXIDE THE PROCTER & GAMBLE COMPANY (US) 1978-12-19 US claimed
US-4046886-A SUGAR ESTER, PHOSPHINE OXIDE THE PROCTER & GAMBLE COMPANY (US) 1977-09-06 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12597611-B2 Cathode for an electrochemical cell including at least one cathode additive EED, SELE, CTNND1 TRPM8 3508/4885LPAR3 4612/4885LPAR2 3918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.